Want to see CGEM full AI Analyst Report?

Cullinan Management (CGEM) Stock Forecast & Price Target

360 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

CGEM Analyst Ratings

Strong Buy

11 Buy

0 Hold

0 Sell

Based on 11 analysts giving stock ratings to

Cullinan

Management

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

CGEM Stock 12 Month Forecast

Average Price Target

$34.11

▲(50.93% Upside)

Based on 11 Wall Street analysts offering 12 month price targets for Cullinan Management in the last 3 months. The average price target is $34.11 with a high forecast of $47.00 and a low forecast of $27.00. The average price target represents a 50.93% change from the last price of $22.60.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"5":"$5","48":"$48","15.75":"$15.75","26.5":"$26.5","37.25":"$37.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":47,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$47.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":34.111111111111114,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$34.11</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":27,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$27.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[5,15.75,26.5,37.25,48],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2025","6":"Mar<br/>2026","9":"Jun<br/>2026","12":"Sep<br/>2026","25":"Sep<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,21.79,23.729230769230767,25.66846153846154,27.607692307692307,29.546923076923076,31.486153846153847,33.425384615384615,35.364615384615384,37.30384615384615,39.24307692307693,41.18230769230769,43.121538461538464,45.06076923076923,{"y":47,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,21.79,22.737777777777776,23.685555555555556,24.633333333333333,25.581111111111113,26.52888888888889,27.476666666666667,28.424444444444447,29.372222222222224,30.32,31.26777777777778,32.215555555555554,33.163333333333334,{"y":34.111111111111114,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,21.79,22.19076923076923,22.591538461538462,22.99230769230769,23.393076923076922,23.793846153846154,24.194615384615386,24.595384615384614,24.996153846153845,25.396923076923077,25.79769230769231,26.198461538461537,26.59923076923077,{"y":27,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":7.49,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.66,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.75,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.35,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.71,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.99,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.94,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.43,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.21,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.28,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.5,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.79,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$47.00

Average Price Target$34.11

Lowest Price Target$27.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Robert Burns

H.C. Wainwright

$30

Buy

32.74%

Upside

Reiterated

08/17/26

Analyst Reiterates Buy on Cullinan as Zipalertinib Progress Supports NDA Path; $30 Price Target Maintained

Sean Laaman

Morgan Stanley

$30

Buy

32.74%

Upside

Assigned

08/17/26

Morgan Stanley Keeps Their Buy Rating on Cullinan Management (CGEM)

David Dai

UBS

$24→$27

Buy

19.47%

Upside

Reiterated

08/17/26

UBS Sticks to Its Buy Rating for Cullinan Management (CGEM)

Kaveri Pohlman

Clear Street

$46→$47

Buy

107.96%

Upside

Assigned

08/14/26

Analysts Offer Insights on Healthcare Companies: Cullinan Management (NASDAQ: CGEM), Cardinal Health (NYSE: CAH) and QT Imaging Holdings (NASDAQ: QTI)

Alex Thompson CFA

Stifel Nicolaus

$28

Buy

23.89%

Upside

Reiterated

08/13/26

Cullinan Management (CGEM) Receives a Rating Update from a Top Analyst

Matt Phipps

William Blair

―

Buy

―

Reiterated

08/13/26

Strong Phase III Zipalertinib Data and Taiho Partnership Drive Matt Phipps’ Buy Rating on Cullinan for Favorable Risk‑Reward

Boris Peaker

JonesTrading

$36

Buy

59.29%

Upside

Reiterated

08/06/26

Cullinan Maintained at Buy as Advancing Autoimmune and Oncology Pipeline Supports Unchanged $36 Price Target

Samantha Semenkow

Citi

$33

Buy

46.02%

Upside

Reiterated

08/06/26

Cullinan Maintained at Buy as Rich Clinical Pipeline and Regulatory Momentum Support Unchanged $33 Price Target

Julian Harrison

BTIG

$38→$39

Buy

72.57%

Upside

Assigned

07/29/26

Analyst Reiterates Buy on CGEM as CLN-049 Advances Toward Registrational Phase 2; Price Target Raised to $39 on Improved Risk-Reward

Robert Driscoll

Wedbush

$37

Buy

63.72%

Upside

Reiterated

07/29/26

Wedbush Sticks to Their Buy Rating for Cullinan Management (CGEM)

Marc Frahm

TD Cowen

―

Buy

―

Reiterated

06/10/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Bradley Canino

Guggenheim

$30

Buy

32.74%

Upside

Reiterated

03/10/26

Guggenheim Reaffirms Their Buy Rating on Cullinan Management (CGEM)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Robert Burns

H.C. Wainwright

$30

Buy

32.74%

Upside

Reiterated

08/17/26

Analyst Reiterates Buy on Cullinan as Zipalertinib Progress Supports NDA Path; $30 Price Target Maintained

Sean Laaman

Morgan Stanley

$30

Buy

32.74%

Upside

Assigned

08/17/26

Morgan Stanley Keeps Their Buy Rating on Cullinan Management (CGEM)

David Dai

UBS

$24→$27

Buy

19.47%

Upside

Reiterated

08/17/26

UBS Sticks to Its Buy Rating for Cullinan Management (CGEM)

Kaveri Pohlman

Clear Street

$46→$47

Buy

107.96%

Upside

Assigned

08/14/26

Analysts Offer Insights on Healthcare Companies: Cullinan Management (NASDAQ: CGEM), Cardinal Health (NYSE: CAH) and QT Imaging Holdings (NASDAQ: QTI)

Alex Thompson CFA

Stifel Nicolaus

$28

Buy

23.89%

Upside

Reiterated

08/13/26

Cullinan Management (CGEM) Receives a Rating Update from a Top Analyst

Matt Phipps

William Blair

―

Buy

―

Reiterated

08/13/26

Strong Phase III Zipalertinib Data and Taiho Partnership Drive Matt Phipps’ Buy Rating on Cullinan for Favorable Risk‑Reward

Boris Peaker

JonesTrading

$36

Buy

59.29%

Upside

Reiterated

08/06/26

Cullinan Maintained at Buy as Advancing Autoimmune and Oncology Pipeline Supports Unchanged $36 Price Target

Samantha Semenkow

Citi

$33

Buy

46.02%

Upside

Reiterated

08/06/26

Cullinan Maintained at Buy as Rich Clinical Pipeline and Regulatory Momentum Support Unchanged $33 Price Target

Julian Harrison

BTIG

$38→$39

Buy

72.57%

Upside

Assigned

07/29/26

Analyst Reiterates Buy on CGEM as CLN-049 Advances Toward Registrational Phase 2; Price Target Raised to $39 on Improved Risk-Reward

Robert Driscoll

Wedbush

$37

Buy

63.72%

Upside

Reiterated

07/29/26

Wedbush Sticks to Their Buy Rating for Cullinan Management (CGEM)

Marc Frahm

TD Cowen

―

Buy

―

Reiterated

06/10/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Bradley Canino

Guggenheim

$30

Buy

32.74%

Upside

Reiterated

03/10/26

Guggenheim Reaffirms Their Buy Rating on Cullinan Management (CGEM)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

BTSGBrightSpring Health Services, Inc.

GPCRStructure Therapeutics, Inc. Sponsored ADR

BLTEBelite Bio, Inc. ADR

AMLXAmylyx Pharmaceuticals Inc

IMMXImmix Biopharma

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Cullinan Management

3 Months

Matt PhippsWilliam Blair

Success Rate

12/16 ratings generated profit

Average Return

+19.82%

Copying Matt Phipps's trades and holding each position for 3 Months would result in 75.00% of your transactions generating a profit, with an average return of +19.82% per trade.

1 Year

Matt PhippsWilliam Blair

Success Rate

15/16 ratings generated profit

Average Return

+82.88%

Copying Matt Phipps's trades and holding each position for 1 Year would result in 93.75% of your transactions generating a profit, with an average return of +82.88% per trade.

2 Years

Julian HarrisonBTIG

Success Rate

17/17 ratings generated profit

Average Return

+109.47%

Copying Julian Harrison's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +109.47% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CGEM Analyst Recommendation Trends

Rating

May 26

Jun 26

Jul 26

Aug 26

Sep 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, CGEM has received 13 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. CGEM average Analyst price target in the past 3 months is 34.11.

Each month's total comprises the sum of three months' worth of ratings.

CGEM Financial Forecast

CGEM Earnings Forecast

Next quarter’s earnings estimate for CGEM is -$0.84 with a range of -$1.04 to -$0.71. The previous quarter’s EPS was -$0.81. CGEM beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year CGEM has Performed in-line its overall industry.

No data currently available

CGEM Sales Forecast

Next quarter’s sales forecast for CGEM is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. CGEM beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year CGEM has Performed in-line its overall industry.

CGEM Stock Forecast FAQ

What is CGEM’s average 12-month price target, according to analysts?

Based on analyst ratings, Cullinan Management’s 12-month average price target is 34.11.

What is CGEM’s upside potential, based on the analysts’ average price target?

Cullinan Management has 50.93% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is CGEM a Buy, Sell or Hold?

Cullinan Management has a consensus rating of Strong Buy which is based on 11 buy ratings, 0 hold ratings and 0 sell ratings.

What is Cullinan Management’s price target?

The average price target for Cullinan Management is 34.11. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $47.00 ,the lowest forecast is $27.00. The average price target represents 50.93% Increase from the current price of $22.6.

What do analysts say about Cullinan Management?

Cullinan Management’s analyst rating consensus is a Strong Buy. This is based on the ratings of 11 Wall Streets Analysts.

How can I buy shares of CGEM?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Cullinan Management (CGEM) Stock Forecast & Price Target

CGEM Analyst Ratings

CGEM Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Cullinan Management

CGEM Analyst Recommendation Trends

CGEM Financial Forecast

CGEM Earnings Forecast

CGEM Sales Forecast

CGEM Stock Forecast FAQ

Detailed List of Analyst Forecasts